Udg Healthcare PLC (LON:UDG) insider Chris Corbin sold 5,650 shares of Udg Healthcare PLC stock in a transaction on Wednesday, June 14th. The stock was sold at an average price of GBX 827 ($10.46), for a total transaction of £46,725.50 ($59,108.79).
Chris Corbin also recently made the following trade(s):
- On Monday, June 5th, Chris Corbin sold 100,000 shares of Udg Healthcare PLC stock. The stock was sold at an average price of GBX 813 ($10.28), for a total transaction of £813,000 ($1,028,463.00).
Shares of Udg Healthcare PLC (LON:UDG) traded up 3.80% during mid-day trading on Friday, hitting GBX 861.50. 2,115,653 shares of the stock were exchanged. Udg Healthcare PLC has a 12 month low of GBX 518.50 and a 12 month high of GBX 861.50. The company has a 50-day moving average price of GBX 786.03 and a 200-day moving average price of GBX 708.80. The stock’s market cap is GBX 2.13 billion.
The firm also recently disclosed a dividend, which will be paid on Tuesday, June 27th. Investors of record on Thursday, June 1st will be given a dividend of $0.04 per share. This represents a dividend yield of 0.35%. The ex-dividend date is Thursday, June 1st.
Several research firms have commented on UDG. Peel Hunt lifted their price objective on shares of Udg Healthcare PLC from GBX 730 ($9.23) to GBX 830 ($10.50) and gave the stock an “add” rating in a research note on Tuesday, May 23rd. Numis Securities Ltd reaffirmed a “hold” rating and set a GBX 730 ($9.23) price objective on shares of Udg Healthcare PLC in a research note on Tuesday, May 23rd. Liberum Capital reaffirmed a “buy” rating and set a GBX 760 ($9.61) price objective on shares of Udg Healthcare PLC in a research note on Monday, April 3rd. Berenberg Bank lowered shares of Udg Healthcare PLC to a “hold” rating and set a GBX 745 ($9.42) price objective for the company. in a research note on Monday, May 15th. Finally, Jefferies Group LLC lowered shares of Udg Healthcare PLC to a “hold” rating and lifted their price objective for the stock from GBX 760 ($9.61) to GBX 785 ($9.93) in a research note on Wednesday, May 24th. Five analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Udg Healthcare PLC currently has a consensus rating of “Hold” and a consensus target price of GBX 773.71 ($9.79).
About Udg Healthcare PLC
UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries.
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/udg-healthcare-plc-udg-insider-chris-corbin-sells-5650-shares/1916644.html
Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with MarketBeat.com's FREE daily email newsletter.